PRF Technologies announced it holds approximately $11 million in cash as of September 30, 2026, with liabilities around $2.5 million. The company is preparing to begin patient enrollment in a U.S. multi-center Phase 2 clinical trial for its OcuRing™-K drug delivery device before year-end. Additionally, PRF is developing GridFeed™, an AI-driven renewable energy platform, as a standalone subsidiary targeting growth in AI data center power optimization, a market expected to double in electricity consumption by 2030. These steps highlight PRF's dual focus on advancing biotech innovations and expanding its AI energy solutions while maintaining financial discipline.
PRF Technologies' recent financial and development update is context for readers following health-sector stocks. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 23, 2026 20:21 WIB: out of 150 priced US health-sector stocks, 28 rose and 119 fell. Notable movers include TNGX at USD 25.63 with a -8.23% change and 100% buy order activity, MRNA at USD 193.00 with a -4.75% change and 71% sell order activity, and NUVB at USD 4.85 with a +3.19% change.
Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
